{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:51:05Z","timestamp":1774605065288,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00284-025-04152-x","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:39:24Z","timestamp":1741340364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and Genetic Profiling of Second-line Drug Resistant Tuberculosis at the Tertiary Care Center of Northern India"],"prefix":"10.1007","volume":"82","author":[{"given":"Nandini","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amresh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5552-2039","authenticated-orcid":false,"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"4152_CR1","unstructured":"WHO (2021). Global Tuberculosis Report 2021. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/globaltuberculosi s-report-2021\/disease-burden\/mortality. Last Access-June 2024"},{"key":"4152_CR2","unstructured":"WHO (2023). Global Tuberculosis Report 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373828\/9789240083851eng.pdf?sequence=1. Last Access-June 2024"},{"key":"4152_CR3","doi-asserted-by":"crossref","unstructured":"Singh N, Singh AK, Kumar S, Singh NP, Gaur V (2022) Role of mycobacterial culture and drug sensitivity testing laboratory under National Tuberculosis Elimination Program for the abolition of tuberculosis in India by 2025. J Clin Diagn Res 16(7): DE01-DE05.","DOI":"10.7860\/JCDR\/2022\/55426.16655"},{"key":"4152_CR4","doi-asserted-by":"publisher","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med 5(9). https:\/\/doi.org\/10.1101\/cshperspect.a017863.","DOI":"10.1101\/cshperspect.a017863"},{"issue":"4","key":"4152_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5799\/ahinjs.02.2013.04.0103","volume":"3","author":"AK Singh","year":"2013","unstructured":"Singh AK, Maurya AK, Kumar M, Kant S, Kushwaha RAS, Nag VL, Dhole TN (2013) Resistance patterns and trends of extensively drug-resistant tuberculosis:5-year experience. J Microbiol Infect Dis 3(4):169\u2013175. https:\/\/doi.org\/10.5799\/ahinjs.02.2013.04.0103","journal-title":"J Microbiol Infect Dis"},{"issue":"2","key":"4152_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/bbrj.bbrj_26_18","volume":"2","author":"A Kumar","year":"2018","unstructured":"Kumar A, Singh AK, Upadhyay V, Pandey J (2018) Epidemiology of multi-drug-resistant tuberculosis in Northern India. Biomed Biotechnol Res J (BBRJ) 2(2):112\u2013121. https:\/\/doi.org\/10.4103\/bbrj.bbrj_26_18","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"4152_CR7","unstructured":"CDC (2024) Clinical Overview of Drug-Resistant Tuberculosis Disease. https:\/\/www.cdc.gov\/tb\/hcp\/clinical-overview\/drug-resistant-tuberculosis-disease.html"},{"issue":"4","key":"4152_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2213-2600(14)70031-1","volume":"2","author":"K Dheda","year":"2014","unstructured":"Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Warren R (2014) Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2(4):321\u2013338. https:\/\/doi.org\/10.1016\/S2213-2600(14)70031-1","journal-title":"Lancet Respir Med"},{"key":"4152_CR9","unstructured":"Global Laboratory Initiative (2022). Line probe assays for drug-resistant tuberculosis detection: Interpretation and reporting guide for laboratory staff and clinicians. https:\/\/stoptb.org\/wg\/gli\/assets\/documents\/LPA_test_web_ready.pdf. Last Access-June 2024"},{"key":"4152_CR10","doi-asserted-by":"crossref","unstructured":"Zhao J, Qian C, Jiang Y, He W, Wu W (2024) Drug-resistant characteristics, genetic diversity, and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Jiangxi, China. Infect Drug Resist 2213\u20132223.","DOI":"10.2147\/IDR.S460267"},{"issue":"4","key":"4152_CR11","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1128\/AAC.01049-15","volume":"60","author":"JY Chien","year":"2016","unstructured":"Chien JY, Chiu WY, Chien ST, Chiang CJ, Yu CJ, Hsueh PR (2016) Mutations in gyrA and gyrB among fluoroquinolone- and multidrug-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 60(4):2090\u20132096. https:\/\/doi.org\/10.1128\/AAC.01049-15","journal-title":"Antimicrob Agents Chemother"},{"key":"4152_CR12","doi-asserted-by":"crossref","unstructured":"Momen G, Aainouss A, Lamaammal A, Chettioui F, Blaghen M, Messoudi M, Chaoui I (2021) Molecular characterization of mutations associated with resistance to second-line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco. Rev Inst Med Trop Sao Paulo 63","DOI":"10.1590\/s1678-9946202163019"},{"issue":"3","key":"4152_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.52711\/0974-360X.2024.00204","volume":"17","author":"N Singh","year":"2024","unstructured":"Singh N, Singh AK, Mishra AK, Singh NP, Kumar S (2024) Estimation of first line anti-tubercular drugs resistance and their genetic analysis by Geno Type MTBDRplus assay from an intermediate reference laboratory in Eastern Uttar Pradesh. India Res J Pharm Technol 17(3):1303\u20131307. https:\/\/doi.org\/10.52711\/0974-360X.2024.00204","journal-title":"India Res J Pharm Technol"},{"key":"4152_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049433","author":"K Ajbani","year":"2012","unstructured":"Ajbani K, Nikam C, Kazi M, Gray C, Boehme C, Balan K, Rodrigues C (2012) Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0049433","journal-title":"PLoS One"},{"key":"4152_CR15","unstructured":"Instructions for use. GenoType MTBDRslVER 2.0 (2017).Available from : https:\/\/www.hain-lifescience.de\/include_datei\/kundenmodule\/packungsbeilage\/downloa d.php?id=2020. Last Access-July 2024"},{"issue":"6","key":"4152_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/medicina59061005","volume":"59","author":"R Gopalaswamy","year":"2023","unstructured":"Gopalaswamy R, Palani N, Viswanathan D, Preysingh B, Rajendran S et al (2023) Resistance profiles to second-line anti-tuberculosis drugs and their treatment outcomes: a three-year retrospective analysis from South India. Medicina (Kaunas) 59(6):1005. https:\/\/doi.org\/10.3390\/medicina59061005","journal-title":"Medicina (Kaunas)"},{"key":"4152_CR17","doi-asserted-by":"publisher","first-page":"e10826","DOI":"10.7717\/peerj.10826","volume":"9","author":"A Saifullah","year":"2021","unstructured":"Saifullah A, Mallhi TH, Khan YH, Iqbal MS, Alotaibi NH, Alzarea AI, Rasheed M (2021) Evaluation of risk factors associated with the development of MDR- and XDR-TB in a tertiary care hospital: a retrospective cohort study. PeerJ 9:e10826. https:\/\/doi.org\/10.7717\/peerj.10826","journal-title":"PeerJ"},{"key":"4152_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijregi.2022.08.012","volume":"5","author":"G Diriba","year":"2022","unstructured":"Diriba G, Alemu A, Tola HH, Yenew B, Amare M, Eshetu K, Abdela S (2022) Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study. IJID Reg 5:39\u201343","journal-title":"IJID Reg"},{"issue":"10","key":"4152_CR19","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.21037\/jtd-23-138","volume":"15","author":"Z Khan","year":"2023","unstructured":"Khan Z, Zhu Y, Guan P, Peng J, Su B, Ma S, Zhang T (2023) Distribution of common and rare drug resistance patterns in Mycobacterium tuberculosis clinical isolates revealed by GenoType MTBDRplus and MTBDRsl assay. J Thorac Dis 15(10):5494","journal-title":"J Thorac Dis"},{"key":"4152_CR20","doi-asserted-by":"crossref","unstructured":"Shibabaw A, Gelaw B, Gebreyes W, Robinson R, Wang SH, Tessema B (2020) The burden of pre extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia. PLoS One 15(2)","DOI":"10.1371\/journal.pone.0229040"},{"key":"4152_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-020-00409-4","volume":"20","author":"K Singh","year":"2021","unstructured":"Singh K, Kumari R, Gupta S, Tripathi R, Srivastava A, Shakya V, Anupurba S (2021) Direct detection of resistance to fluoroquinolones\/SLIDs in sputum specimen by genotype MTBDR sl v. 2.0 assay: a study from Eastern Uttar Pradesh. India Ann Clin Microbiol Antimicrob 20:1\u20136","journal-title":"India Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"4152_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0022-3859.118034","volume":"59","author":"AK Singh","year":"2013","unstructured":"Singh AK, Maurya AK, Kant S, Umrao J, Kushwaha RAS, Nag VL, Dhole TN (2013) Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType\u00ae MTBDRsl assay. J Postgrad Med 59(3):179\u2013185","journal-title":"J Postgrad Med"},{"key":"4152_CR23","doi-asserted-by":"crossref","unstructured":"Rufai SB, Umay K, Singh PK, Singh S (2020) Performance of Genotype MTBDR sl V2.0 over the Genotype MTBDR sl V1 for detection of second line drug resistance: an Indian perspective. PLoS One 15(3).","DOI":"10.1371\/journal.pone.0229419"},{"issue":"1","key":"4152_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2991\/jegh.k.191215.003","volume":"10","author":"S Sethi","year":"2020","unstructured":"Sethi S, Agarwal P, Khaneja R, Kumar N, Kumar N, Chandna J, Yadav R (2020) Second-line drug resistance characterization in Mycobacterium tuberculosis by genotype MTBDRsl assay. J Epidemiol Glob Health 10(1):42\u201345","journal-title":"J Epidemiol Glob Health"},{"key":"4152_CR25","doi-asserted-by":"crossref","unstructured":"Bouzouita I, Draoui H, Cabibbe AM, Essalah L, Bejaoui S, Trovato A, Slim-Saidi L (2021) Performance of the GenoType MTBDRsl V2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia. Res Microbiol 172(3):103816.","DOI":"10.1016\/j.resmic.2021.103816"},{"issue":"2","key":"4152_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/ijmy.ijmy_70_22","volume":"11","author":"RN Yadav","year":"2022","unstructured":"Yadav RN, Bhalla M, Kumar G, Sah GC, Dewan RK, Singhal R (2022) Diagnostic utility of GenoType MTBDRsl assay for the detection of moxifloxacin-resistant Mycobacterium tuberculosis, as compared to phenotypic method and whole-genome sequencing. Int J Mycobacteriol 11(2):183\u2013189","journal-title":"Int J Mycobacteriol"},{"issue":"6","key":"4152_CR27","doi-asserted-by":"publisher","first-page":"e40442","DOI":"10.7759\/cureus.40442","volume":"15","author":"RK Sharma","year":"2023","unstructured":"Sharma RK, Kumari U, Kumari N, Kumar R (2023) Characterization of genetic mutations in multi-drug-resistant isolates of Mycobacterium tuberculosis Bacilli conferring resistance to a second-line anti-tuberculosis drug. Cureus 15(6):e40442. https:\/\/doi.org\/10.7759\/cureus.40442","journal-title":"Cureus"},{"issue":"1","key":"4152_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12879-023-08130-1","volume":"23","author":"Y Pan","year":"2023","unstructured":"Pan Y, Yu Y, Yi Y, Dou X, Lu J, Zhou L (2023) The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study. BMC Infect Dis 23(1):162","journal-title":"BMC Infect Dis"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04152-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T05:54:00Z","timestamp":1742363640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04152-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4152"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04152-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Institutional Human Ethical Committee of BRD Medical College, Gorakhpur (S. No. 11\/IHEC\/2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"176"}}